alexa European Council’s Recent Revision in MedDev 2.7.1 Guidelines (Revision 4) – Quantifying its Change and its Impact
ISSN: 2155-9538

Journal of Bioengineering & Biomedical Science
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

European Council’s Recent Revision in MedDev 2.7.1 Guidelines (Revision 4) – Quantifying its Change and its Impact

Ashish I*

Domain consultant, Tata Consultancy Services, Mumbai, India

*Corresponding Author:
Ashish I
Domain consultant
Tata Consultancy Services
Mumbai 444602, India
Tel: +91.98333.16130
E-mail: [email protected]

Received Date: 30, March 2017; Accepted Date: 18, April 2017; Published Date: 25, April 2017

Citation: Ashish Indani (2017) European Council’s Recent Revision in MedDev 2.7.1 Guidelines (Revision 4) – Quantifying its Change and its Impact. J Bioengineer & Biomedical Sci 7: 225. doi:10.4172/2155-9538.1000225

Copyright: © 2017 Ashish I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Latest updates in guidelines of European Union for medical device clinical evaluation report (CER) is particularly in line with the shift of focus of evaluation process from “verification of safety and performance” to justification of “sufficient evidence conforming to the essential requirements” and subsequent change in the approach of clinical evaluation from a subjective justification based upon collection of information to an objective, holistic and logical clinical justification based upon clear and rational methods. Stating that the clinical evaluators need to have an experience of about 10 years in clinical research and medical writing, requiring an all-inclusive state-of-the-art for device-treated disease, and specifying clinical data sources, the guidelines have given a direction for CER to be logical and objective. The requirement to align manufacturer supplied information such as instructions for use, Clinical Investigations Report and CER is indicative of the holistic approach. These guidelines are not effective immediately, however, their merits and value addition as well as its immediate implantation is practical and operationally beneficial for the manufacturers. They have removed ambiguities about the qualifications, acceptability standards of performance and safety of the device, scope of clinical evaluation etc. and have set expectations. The guidelines are supposed to bring about two major changes in the CER trends. The first change will be in the trend of personnel. We can now expect increased engagement for medical writer with 10 years of more experience. In addition, organizations with personnel having diverse background will be in a better position to deliver the CER. Due to increased engagement in PMS, PMCF and registry activities, increased literature search and summarization requirements and frequent update of CER, need for automation will increase.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords